Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,530 | 3,330 | 2,060 | 630 | 810 |
| TOTAL | $2,530 | $3,330 | $2,060 | $630 | $810 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 5,730 | 4,930 | 5,090 | 5,390 | 5,700 |
| TOTAL | $5,730 | $4,930 | $5,090 | $5,390 | $5,700 |
| Total Assets | $8,260 | $8,260 | $7,150 | $6,020 | $6,510 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 940 | 620 | 990 | 1,220 | 870 |
| Accrued Expenses | 3,730 | 5,410 | 3,640 | 4,590 | 3,970 |
| Other current liabilities | 680 | 150 | 150 | 360 | 580 |
| TOTAL | $6,540 | $7,690 | $6,500 | $8,180 | $7,710 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,660 | 3,000 | 0 | 0 | 0 |
| TOTAL | $3,380 | $5,180 | $1,960 | $1,560 | $1,690 |
| Total Liabilities | $9,920 | $12,870 | $8,460 | $9,740 | $9,400 |
| Shareholders' Equity | |||||
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Other shareholders' equity | 260 | -440 | -620 | -1,150 | -1,750 |
| TOTAL | $197,910 | $193,770 | $193,320 | $192,320 | $190,840 |
| Total Liabilities And Equity | $207,830 | $206,640 | $201,780 | $202,060 | $200,240 |